|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.330 CNY | +2.37% |
|
+4.27% | -15.16% |
| Market Cap | 3.74B 551M 482M 443M 413M 783M 52.51B 795M 5.32B 2.07B 25.81B 2.07B 2.03B 88.94B | P/E 2024 |
65.6x | P/E 2025 | 89.6x |
|---|---|---|---|---|---|
| Enterprise Value | 3.26B 481M 420M 386M 360M 683M 45.79B 693M 4.64B 1.8B 22.51B 1.81B 1.77B 77.56B | EV / Sales 2024 |
3.66x | EV / Sales 2025 | 4.3x |
| Free-Float |
33.21% | Yield 2024 |
0.16% | Yield 2025 | 0.23% |
| 1 day | +2.37% | ||
| 1 week | +4.27% | ||
| Current month | +7.64% | ||
| 1 month | -4.56% | ||
| 3 months | -15.16% | ||
| 6 months | -15.16% | ||
| Current year | -15.16% |
| 1 week | 6.63 | 7.35 | |
| 1 month | 6.63 | 7.73 | |
| Current year | 6.63 | 11.02 | |
| 1 year | 6.63 | 11.85 | |
| 3 years | 5.84 | 12.18 | |
| 5 years | 5.84 | 15.17 | |
| 10 years | 5.84 | 15.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ai Guo Shi
CEO | Chief Executive Officer | 62 | 2022-04-05 |
Jin feng Yue
DFI | Director of Finance/CFO | - | 2022-12-01 |
Li Jun Wu
PRN | Corporate Officer/Principal | 52 | 2018-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Wen Bo Su
CHM | Chairman | 60 | 2014-05-07 |
Ai Guo Shi
CHM | Chairman | 62 | 2017-06-29 |
Zhi Jun Liu
BRD | Director/Board Member | 54 | 2016-04-11 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.37% | +4.27% | -13.87% | -39.82% | 551M | ||
| +0.21% | +3.96% | -12.47% | -7.71% | 12.84B | ||
| +0.34% | +4.33% | -34.57% | -57.93% | 4.72B | ||
| +2.23% | +12.59% | +17.91% | -6.37% | 3.91B | ||
| +1.10% | +6.55% | +4.13% | -39.43% | 3.84B | ||
| +0.13% | -11.54% | -14.01% | -20.23% | 3.05B | ||
| +1.74% | +5.74% | -11.17% | -1.48% | 3.08B | ||
| +0.79% | +6.47% | -7.22% | -25.40% | 2.38B | ||
| +0.53% | +7.02% | -14.09% | +33.06% | 1.72B | ||
| +2.59% | +8.49% | -11.64% | -14.77% | 1.69B | ||
| Average | +1.20% | +0.43% | -9.70% | -18.01% | 3.78B | |
| Weighted average by Cap. | +0.83% | +0.17% | -10.14% | -17.61% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 980M 144M 126M 116M 108M 205M 13.75B 208M 1.39B 541M 6.76B 542M 530M 23.29B | 916M 135M 118M 108M 101M 192M 12.84B 194M 1.3B 506M 6.31B 506M 495M 21.75B |
| Net income | 60.07M 8.85M 7.74M 7.11M 6.63M 12.57M 843M 12.76M 85.35M 33.18M 414M 33.22M 32.51M 1.43B | 49.21M 7.25M 6.34M 5.82M 5.43M 10.3M 690M 10.45M 69.92M 27.18M 339M 27.21M 26.63M 1.17B |
| Net Debt | -357M -52.61M -45.99M -42.27M -39.4M -74.73M -5.01B -75.86M -507M -197M -2.46B -197M -193M -8.48B | -479M -70.57M -61.69M -56.69M -52.85M -100M -6.72B -102M -681M -265M -3.3B -265M -259M -11.38B |
Employees
1,332
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-03 | CN¥7.330 | +2.37% | 4,111,900 |
| 26-07-02 | CN¥7.160 | +1.56% | 4,391,350 |
| 26-07-01 | CN¥7.050 | +3.52% | 6,086,950 |
| 26-06-30 | CN¥6.810 | -5.15% | 9,294,400 |
| 26-06-29 | CN¥7.180 | +2.13% | 4,312,800 |
- Stock Market
- Stocks
- 002644 Stock
Select your edition
All financial news and data tailored to specific country editions
















